398 related articles for article (PubMed ID: 19258928)
1. Multi-site analytical evaluation of the Abbott ARCHITECT tacrolimus assay.
Wallemacq P; Goffinet JS; O'Morchoe S; Rosiere T; Maine GT; Labalette M; Aimo G; Dickson D; Schmidt E; Schwinzer R; Schmid RW
Ther Drug Monit; 2009 Apr; 31(2):198-204. PubMed ID: 19258928
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of 2 immunoassays for monitoring low blood levels of tacrolimus.
Amann S; Parker TS; Levine DM
Ther Drug Monit; 2009 Apr; 31(2):273-6. PubMed ID: 19142177
[TBL] [Abstract][Full Text] [Related]
3. Analytical performance characteristics of the Abbott Architect i2000 Tacrolimus assay; comparisons with liquid chromatography-tandem mass spectrometry (LC-MS/MS) and Abbott IMx methods.
De BK; Jimenez E; De S; Sawyer JC; McMillin GA
Clin Chim Acta; 2009 Dec; 410(1-2):25-30. PubMed ID: 19751714
[TBL] [Abstract][Full Text] [Related]
4. Multisite analytical evaluation of the Abbott ARCHITECT cyclosporine assay.
Wallemacq P; Maine GT; Berg K; Rosiere T; Marquet P; Aimo G; Mengozzi G; Young J; Wonigeit K; Kretschmer R; Wermuth B; Schmid RW
Ther Drug Monit; 2010 Apr; 32(2):145-51. PubMed ID: 20216110
[TBL] [Abstract][Full Text] [Related]
5. Multi-site analytical evaluation of a chemiluminescent magnetic microparticle immunoassay (CMIA) for sirolimus on the Abbott ARCHITECT analyzer.
Schmid RW; Lotz J; Schweigert R; Lackner K; Aimo G; Friese J; Rosiere T; Dickson D; Kenney D; Maine GT
Clin Biochem; 2009 Oct; 42(15):1543-8. PubMed ID: 19563794
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the Architect tacrolimus assay in kidney, liver, and heart transplant recipients.
Bazin C; Guinedor A; Barau C; Gozalo C; Grimbert P; Duvoux C; Furlan V; Massias L; Hulin A
J Pharm Biomed Anal; 2010 Dec; 53(4):997-1002. PubMed ID: 20674215
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the Abbott ARCHITECT i2000 sirolimus assay and comparison with the Abbott IMx sirolimus assay and an established liquid chromatography-tandem mass spectrometry method.
Johnson-Davis KL; De S; Jimenez E; McMillin GA; De BK
Ther Drug Monit; 2011 Aug; 33(4):453-9. PubMed ID: 21743377
[TBL] [Abstract][Full Text] [Related]
8. Performance of a no-pretreatment tacrolimus assay on the Dade Behring Dimension RxL clinical chemistry analyzer.
Griffey MA; Hock KG; Kilgore DC; Wei TQ; Duh SH; Christenson R; Scott MG
Clin Chim Acta; 2007 Sep; 384(1-2):48-51. PubMed ID: 17588555
[TBL] [Abstract][Full Text] [Related]
9. Application of the EMIT 2000 Tacrolimus assay on the Abbott Architect c8000 high volume clinical chemistry analyzer.
Boer K; Deufel T; Schmidt D; Streck S; Kiehntopf M
Clin Biochem; 2006 Oct; 39(10):1041-3. PubMed ID: 16979616
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the CEDIA and MEIA assays for measurement of tacrolimus in organ transplant recipients.
Liang SL; Breaud A; Dunn W; Clarke W
Clin Chim Acta; 2008 Oct; 396(1-2):1-6. PubMed ID: 18606158
[TBL] [Abstract][Full Text] [Related]
11. Multi-center evaluation of analytical performance of the microparticle enzyme immunoassay for sirolimus.
Wilson D; Johnston F; Holt D; Moreton M; Engelmayer J; Gaulier JM; Luthe H; Marquet P; Moscato D; Oellerich M; Mosso R; Streit F; Brunet M; Fillee C; Schmid R; Wallemacq P; Barnes G
Clin Biochem; 2006 Apr; 39(4):378-86. PubMed ID: 16545357
[TBL] [Abstract][Full Text] [Related]
12. Is the affinity column-mediated immunoassay method suitable as an alternative to the microparticle enzyme immunoassay method as a blood tacrolimus assay?
Ju MK; Chang HK; Kim HJ; Huh KH; Ahn HJ; Kim MS; Kim SI; Kim YS
Transplant Proc; 2008 Dec; 40(10):3673-8. PubMed ID: 19100463
[TBL] [Abstract][Full Text] [Related]
13. Analytical performance of the Abbott Architect i2000 tacrolimus assay in Chinese patients after renal transplantation.
Li ZY; Yan CL; Yan R; Feng ZR
Transplant Proc; 2010 Dec; 42(10):4534-7. PubMed ID: 21168731
[TBL] [Abstract][Full Text] [Related]
14. [Performance evaluation of affinity column mediated immunometric assay for tacrolimus].
Chung JW; An D; Song J; Chung HJ; Park HI; Lee W; Chun S; Min WK
Korean J Lab Med; 2009 Oct; 29(5):415-22. PubMed ID: 19893350
[TBL] [Abstract][Full Text] [Related]
15. Validation of a liquid chromatography-mass spectrometric assay for tacrolimus in peripheral blood mononuclear cells.
Capron A; Musuamba F; Latinne D; Mourad M; Lerut J; Haufroid V; Wallemacq PE
Ther Drug Monit; 2009 Apr; 31(2):178-86. PubMed ID: 19057467
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic monitoring of tacrolimus: aberrant results by an immunoassay with automated pretreatment.
Moscato D; Nonnato A; Adamo R; Vancheri M; Caropreso A
Clin Chim Acta; 2010 Jan; 411(1-2):77-80. PubMed ID: 19835852
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the CEDIA and MEIA assays for the measurement of sirolimus in organ transplant recipients.
Colantonio DA; Borden KK; Clarke W
Clin Biochem; 2007 Jun; 40(9-10):680-7. PubMed ID: 17428457
[TBL] [Abstract][Full Text] [Related]
18. The EMIT 2000 tacrolimus assay: an application protocol for the Beckman Synchron LX20 PRO analyzer.
LeGatt DF; Shalapay CE; Cheng SB
Clin Biochem; 2004 Nov; 37(11):1022-30. PubMed ID: 15498532
[TBL] [Abstract][Full Text] [Related]
19. Robust, high-throughput LC-MS/MS method for therapeutic drug monitoring of cyclosporine, tacrolimus, everolimus, and sirolimus in whole blood.
Koster RA; Dijkers EC; Uges DR
Ther Drug Monit; 2009 Feb; 31(1):116-25. PubMed ID: 19065123
[TBL] [Abstract][Full Text] [Related]
20. Cloned enzyme donor immunoassay tacrolimus assay compared with high-performance liquid chromatography-tandem mass spectrometry and microparticle enzyme immunoassay in liver and renal transplant recipients.
Westley IS; Taylor PJ; Salm P; Morris RG
Ther Drug Monit; 2007 Oct; 29(5):584-91. PubMed ID: 17898648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
